REPRONEST
Live / Applied — Non-final action written — not yet mailed (as of 29 Sept 2026)
What this means for you
Not registered yet, but its 22 Jun 2026 filing date beats anything filed after it. If it registers, the owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 79456705
- Mark type
- Word mark
- Filed
- 22 Jun 2026
Goods and services
- Class 001 — Chemicals: Stem cells for scientific or research purposes
- Class 005 — Pharmaceuticals: Ovarian somatic cells derived from stem cells, for medical use
- Class 042 — Scientific and technological services: Culturing of cells for scientific research purposes in the field of fertility treatment; stem cell research services in the field of fertility treatment; medical research services in the field of fertility treatment
- Class 044 — Medical, beauty and agricultural services: Storage and supply of human oocytes for medical purposes; advisory and consultancy services relating to fertility treatment
Owner
- Dioseve Inc., JP
Prosecution history
- 30 Sept 2026 — NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
- 29 Sept 2026 — NON-FINAL ACTION WRITTEN
- 28 Sept 2026 — ASSIGNED TO EXAMINER
- 25 Aug 2026 — APPLICATION FILING RECEIPT MAILED
- 25 Aug 2026 — NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
- 24 Aug 2026 — LIMITATION FROM ORIGINAL APPLICATION ENTERED
- 20 Aug 2026 — SN ASSIGNED FOR SECT 66A APPL FROM IB